BHG News and Press, Bright Health Group Inc. From 03/09/22

Bright Health Group (BHG +21.4%) gains as Director Kadre Family Partnership bought 200K shares at price range of $2.04 - $2.13 each, worth ~ $420K. Quick look at the company's ownership structure: For further details see: Bright Health Group stock gains as Director buys 200K s...

Gainers: Sunshine Biopharma (NASDAQ:SBFM) +159%. Cano Health (NYSE:CANO) +34%. Celyad Oncology (NASDAQ:CYAD) +24%. Mainz Biomed (NASDAQ:MYNZ) +21%. Bright Health Group (NYSE:BHG) +17%. Losers: Ontrak (NASDAQ:OTRK) -20%. Invacare (NYSE:IVC) -19%. Na...

Sunshine Biopharma (NASDAQ:SBFM) +201% on rising volume. American Rebel Holdings (NASDAQ:AREB) +28%. Bumble (NASDAQ:BMBL) +23% on Q4 results. Ecoark Holdings (NASDAQ:ZEST) +22% announces successful drilling of Louisiana oil well. Imperial Petroleum (NASDAQ:IMPP) ...

Gainers: DBV Technologies (NASDAQ:DBVT) +16%. EyePoint Pharmaceuticals (NASDAQ:EYPT) +14%. Antares Pharma (NASDAQ:ATRS) +10%. Nuvalent (NASDAQ:NUVL) +8%. Aquestive Therapeutics (NASDAQ:AQST) +7%. Losers: NuCana (NASDAQ:NCNA) -54%. MediWound (NASDAQ:MDWD) -15%.&#x...

Image source: The Motley Fool. Bright Health Group, Inc. (NYSE: BHG) Q4 2021 Earnings Call Mar 02, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Bright Health Group, Inc. (BHG) Q4 2021 Earnings Call Transcript

BofA Securities has issued a double downgrade of Bright Health Group (BHG -10.1%) following the company's Q4 2021 results that missed on the top and bottom lines. The firm has downgraded the stock to underperform from buy and lowered its price target to $2.50 from $6 (~20% downside based on T...

The following slide deck was published by Bright Health Group, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Bright Health Group, Inc. 2021 Q4 - Results - Earnings Call Presentation

Bright Health Group, Inc. (BHG) Q4 2021 Earnings Conference Call March 2, 2022 8:00 A.M. ET Company Participants Stephen Hagan - Director, Investor Relations Mike Mikan - President and Chief Executive Officer Cathy Smith - Chief Financial Officer and Chief Administrative Officer Conference Ca...

Bright Health (BHG -15.5%) stock plunged following its Q4 results which failed to beat analysts' estimates. "While progressing on important foundational capabilities, this level of growth created challenges during the year which resulted in worse than expected performance,” said Bright...

Gainers: Organogenesis (NASDAQ:ORGO) +24%. CytomX Therapeutics (NASDAQ:CTMX) +13%. X4 Pharmaceuticals (NASDAQ:XFOR) +13%. MannKind (NASDAQ:MNKD) +10%. Allied Healthcare (NASDAQ:AHPI) +6%. Losers: Karyopharm Therapeutics (NASDAQ:KPTI) -31%. Bright Health Grou...